O'Toole David D
- SEC CIK
- 0001491140
In the past year, 5 open-market purchase filings worth $46.0K and no sales.
Current role at each company
- RCEL AVITA Medical, Inc.CFOas of Aug 24, 2026
- OPNT Opiant Pharmaceuticals, Inc.Chief Financial Officeras of Mar 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $46.0K
- 5 filings
- Sold
- –
- 0 filings
- Net
- +$46.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists O'Toole David D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RCEL AVITA Medical, Inc.
CFO20 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2023 (view filing) | Jun 20 | 1 day | O'Toole David DCFO | PPurchase | +1.00K | $16.15 | +$16.1K | +100.0%2.00K after | |
| Aug 15, 2023 (view filing) | Aug 15 | Same day | O'Toole David DCFO | PPurchase | +5.00K | $17.93 | +$89.6K | +250.0%7.00K after | 5 lots |
| Aug 16, 2023 (view filing) | Aug 16 | Same day | O'Toole David DCFO | PPurchase | +2.00K | $17.06 | +$34.1K | +28.6%9.00K after | 2 lots |
| Nov 15, 2023 (view filing) | Nov 14-15 | 1 day | O'Toole David DCFO | PPurchase | +2.00K | $13.07 | +$26.1K | +22.2%11.0K after | 2 lots |
| Nov 16, 2023 (view filing) | Nov 15-16 | 1 day | O'Toole David DCFO | PPurchase | +2.00K | $12.30 | +$24.6K | +18.2%13.0K after | 2 lots |
| Nov 21, 2023 (view filing) | Nov 21 | Same day | O'Toole David DCFO | PPurchase | +2.00K | $10.28 | +$20.6K | +15.4%15.0K after | 2 lots |
| Dec 4, 2023 (view filing) | Dec 1 | 3 days | O'Toole David DCFO | PPurchase | +500 | $10.68 | +$5.34K | +3.1%16.5K after | |
| Dec 12, 2023 (view filing) | Dec 12 | Same day | O'Toole David DCFO | PPurchase | +950 | $12.45 | +$11.8K | +5.7%17.5K after | |
| Feb 28, 2024 (view filing) | Feb 28 | Same day | O'Toole David DCFO | PPurchase | +1.25K | $17.39 | +$21.7K | +7.1%18.7K after | 2 lots |
| Jun 3, 2024 (view filing) | May 30 | 4 days | O'Toole David DCFO | PPurchase | +1.00K | $8.90 | +$8.90K | +5.3%19.7K after | 2 lots |
OPNT Opiant Pharmaceuticals, Inc.
Chief Financial Officer7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 (view filing) | Aug 16 | Same day | O'Toole David DChief Financial Officer | PPurchase | +600 | $15.38 | +$9.23K | +2.6%23.8K after | |
| Sep 15, 2021 (view filing) | Sep 14 | 1 day | O'Toole David DChief Financial Officer | PPurchase | +200 | $19.12 | +$3.82K | +0.8%24.0K after | 2 lots |
| Jan 12, 2022 (view filing) | Jan 10 | 2 days | O'Toole David DChief Financial Officer | SSale | −432 | $30.60 | −$13.2K | −1.2%35.6K after | |
| Jul 15, 2022 (view filing) | Jul 14 | 1 day | O'Toole David DChief Financial Officer | SSale | −779 | $11.10 | −$8.65K | −2.1%36.8K after | |
| Jan 5, 2023 (view filing) | Jan 5 | Same day | O'Toole David DChief Financial Officer | SSale | −1.60K | $20.20 | −$32.3K | −4.3%35.2K after | |
| Jan 9, 2023 (view filing) | Jan 9 | Same day | O'Toole David DChief Financial Officer | SSale | −415 | $20.20 | −$8.38K | −1.2%34.8K after | |
| Jan 31, 2023 (view filing) | Jan 27 | 4 days | O'Toole David DChief Financial Officer | SSale | −541 | $20.26 | −$11.0K | −1.6%34.2K after |